Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Cancer Medicine
|
August 12, 2025
Rethinking Radiation Therapy for Perineural Invasion in Oral Cancer: Does More Coverage Improve Outcomes?
Sarbani Ghosh Laskar, Anuj Kumar, Ashwini Adhau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
Sarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
Head & Neck
|
March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis
Sarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2025
Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843)
Sarbani Ghosh Laskar, Sahil Sood, Abhishek Chatterjee, et al.
Head & Neck
|
March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute
Sarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
South Asian Journal of Cancer
|
December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer Cohort
Sarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
Vijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Cancer Medicine
|
August 12, 2025
Rethinking Radiation Therapy for Perineural Invasion in Oral Cancer: Does More Coverage Improve Outcomes?
Sarbani Ghosh Laskar, Anuj Kumar, Ashwini Adhau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
Sarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
Head & Neck
|
March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis
Sarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2025
Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843)
Sarbani Ghosh Laskar, Sahil Sood, Abhishek Chatterjee, et al.
Head & Neck
|
March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute
Sarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
South Asian Journal of Cancer
|
December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer Cohort
Sarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation
Vijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Page
of 4